Our laboratory and others have shown end-gestational IL-1 blockade to be placento- and neuro-protective in LPS-induced chorioamnionitis and reduce subsequent neurodevelopmental anomalies (7, 8, 11, 28). Here, IL1B is linked to chorioamnionitis.